1. Home
  2. PLOW vs CGEM Comparison

PLOW vs CGEM Comparison

Compare PLOW & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Dynamics Inc.

PLOW

Douglas Dynamics Inc.

N/A

Current Price

$42.65

Market Cap

934.7M

Sector

Industrials

ML Signal

N/A

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

N/A

Current Price

$13.59

Market Cap

794.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PLOW
CGEM
Founded
1948
2016
Country
United States
United States
Employees
1764
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
934.7M
794.7M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
PLOW
CGEM
Price
$42.65
$13.59
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$51.50
$30.11
AVG Volume (30 Days)
251.0K
702.8K
Earning Date
05-04-2026
03-10-2026
Dividend Yield
2.91%
N/A
EPS Growth
N/A
N/A
EPS
1.96
N/A
Revenue
$656,053,000.00
N/A
Revenue This Year
$12.15
N/A
Revenue Next Year
$5.36
$79.85
P/E Ratio
$20.57
N/A
Revenue Growth
15.40
N/A
52 Week Low
$21.30
$5.68
52 Week High
$47.16
$16.74

Technical Indicators

Market Signals
Indicator
PLOW
CGEM
Relative Strength Index (RSI) 53.84 50.57
Support Level $28.65 $11.43
Resistance Level $47.16 $16.74
Average True Range (ATR) 1.21 0.89
MACD -0.38 -0.28
Stochastic Oscillator 46.76 32.06

Price Performance

Historical Comparison
PLOW
CGEM

About PLOW Douglas Dynamics Inc.

Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for autoimmune diseases and cancer. Its development pipeline comprises the following drug candidates: CLN-978, a CD19xCD3 bispecific T cell engager that is being developed for autoimmune diseases; CLN-049, a FLT3xCD3 bispecific T cell engager being evaluated in an ongoing clinical trial in patients with relapsed/refractory acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS); Velinotamig, a BCMAxCD3 bispecific T cell engager being developed to counter autoimmune diseases; and Zipalertinib, being developed as a treatment for non-small cell lung cancer. Additionally, the company is developing several preclinical programs in autoimmune diseases and oncology.

Share on Social Networks: